Status:
RECRUITING
Prospective Study of White Blood Cells
Lead Sponsor:
Quell Therapeutics Limited
Conditions:
Autoimmune Diseases
Inflammation
Eligibility:
All Genders
Brief Summary
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Eligibility Criteria
Inclusion
- No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.
Exclusion
Key Trial Info
Start Date :
March 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04838171
Start Date
March 24 2021
End Date
December 1 2024
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quell Investigator Site 01
London, United Kingdom